検索結果 - Hubert G. M. Leufkens

Relationship between Age and the Ability to Break Scored Tablets 著者: Kim Notenboom, Kim Notenboom, Herman Vromans, Herman Vromans, Maarten Schipper, Hubert G.M. Leufkens, Hubert G.M. Leufkens, Marcel Louis Bouvy, Marcel Louis Bouvy

Connect to this object online.

Getting the Right Evidence After Drug Approval 著者: Rick A. Vreman, Rick A. Vreman, Hubert G. M. Leufkens, Aaron S. Kesselheim

Connect to this object online.

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil 著者: Yared Santa-, Veronika J Wirtz, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse

Connect to this object online.

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003-2019 著者: Zuzana Kusynová, Hendrika A. van den Ham, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences 著者: H. Hilda Ampadu, Jarno Hoekman, Daniel Arhinful, Marilyn Amoama-Dapaah, Hubert G. M. Leufkens, Alex N. O. Dodoo

Connect to this object online.

Medicine shortages: impact behind numbers 著者: Doerine J. Postma, Kim Notenboom, Peter A. G. M. De Smet, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Impact of medicine shortages on patients - a framework and application in the Netherlands 著者: Doerine J. Postma, Peter A. G. M. De Smet, Kim Notenboom, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile 著者: Ting Wang, Ting Wang, Neil McAuslane, Wim G. Goettsch, Wim G. Goettsch, Hubert G. M. Leufkens, Marie L. De Bruin

Connect to this object online.

Drug Repurposing for Rare Diseases: A Role for Academia 著者: Sibren van den Berg, Sibren van den Berg, Saco de Visser, Hubert G.M. Leufkens, Carla E.M. Hollak, Carla E.M. Hollak

Connect to this object online.

Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study 著者: Doerine J Postma, Magali L A Heijkoop, Peter A G M De Smet, Kim Notenboom, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse

Connect to this object online.

Switching TNFα inhibitors: Patterns and determinants 著者: Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens, Thijs J. Giezen

Connect to this object online.

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies 著者: Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse

Connect to this object online.

Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study 著者: Doerine J. Postma, Doerine J. Postma, Peter A. G. M. De Smet, Peter A. G. M. De Smet, Christine C. Gispen-de Wied, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems 著者: Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward, Jude Nwokike

Connect to this object online.